EDWARDS LIFESCIENCES CORP (1EW.MI) Stock Price, Forecast & Analysis
BIT:1EW • US28176E1082
1EW.MI Key Statistics, Chart & Performance
The current stock price of 1EW.MI is 65.35 EUR.
1EW.MI Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to 1EW.MI.
1EW.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to 1EW.MI. 1EW.MI scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
1EW.MI Financial Highlights
Over the last trailing twelve months 1EW.MI reported a non-GAAP Earnings per Share(EPS) of 2.17. The EPS decreased by -3.75% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 23.25% | ||
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| Debt/Equity | 0.06 |
1EW.MI Forecast & Estimates
42 analysts have analysed 1EW.MI and the average price target is 82.88 EUR. This implies a price increase of 26.82% is expected in the next year compared to the current price of 65.35.
For the next year, analysts expect an EPS growth of 1.27% and a revenue growth 4.63% for 1EW.MI
1EW.MI Ownership
1EW.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 2M6 | MEDTRONIC PLC | 15.75 | 109.407B | ||
| 1MDT | MEDTRONIC PLC | 16.18 | 108.304B | ||
| SHL | SIEMENS HEALTHINEERS AG | 15.27 | 46.169B | ||
| 1PHIA | KONINKLIJKE PHILIPS NV | 17.38 | 25.46B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 17.22 | 24.921B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 17.19 | 24.882B | ||
| BIM | BIOMERIEUX | 18.48 | 10.913B | ||
| DIA | DIASORIN SPA | 16.37 | 4.014B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 17.93 | 3.702B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 11.44 | 2.311B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1EW.MI
Company Profile
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. The company is headquartered in Irvine, California and currently employs 15,800 full-time employees. The company went IPO on 2000-03-27. The firm partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. The company provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. The company is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.
Company Info
EDWARDS LIFESCIENCES CORP
One Edwards Way
Irvine CALIFORNIA US
Employees: 15800
Phone: 13026587581
EDWARDS LIFESCIENCES CORP / 1EW.MI FAQ
Can you describe the business of EDWARDS LIFESCIENCES CORP?
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. The company is headquartered in Irvine, California and currently employs 15,800 full-time employees. The company went IPO on 2000-03-27. The firm partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. The company provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. The company is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.
What is the stock price of EDWARDS LIFESCIENCES CORP today?
The current stock price of 1EW.MI is 65.35 EUR. The price decreased by -7.65% in the last trading session.
Does EDWARDS LIFESCIENCES CORP pay dividends?
1EW.MI does not pay a dividend.
What is the ChartMill rating of EDWARDS LIFESCIENCES CORP stock?
1EW.MI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
What sector and industry does EDWARDS LIFESCIENCES CORP belong to?
EDWARDS LIFESCIENCES CORP (1EW.MI) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the Price/Earnings (PE) ratio of EDWARDS LIFESCIENCES CORP (1EW.MI)?
The PE ratio for EDWARDS LIFESCIENCES CORP (1EW.MI) is 30.12. This is based on the reported non-GAAP earnings per share of 2.17 and the current share price of 65.35 EUR.
What is the market capitalization of 1EW stock?
EDWARDS LIFESCIENCES CORP (1EW.MI) has a market capitalization of 37.92B EUR. This makes 1EW.MI a Large Cap stock.